• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进展期胃癌:一种新的外科与肿瘤学联合治疗方法。

Advanced gastric cancer: a new combined surgical and oncological approach.

作者信息

Kremer B, Henne-Bruns D, Weh H J, Effenberger T

机构信息

Dept. of Surgery, University of Hamburg.

出版信息

Hepatogastroenterology. 1989 Feb;36(1):23-6.

PMID:2744710
Abstract

Forty-two patients with advanced gastric carcinoma underwent chemotherapy in accordance with the FAMTX protocol. Complete tumor remission was achieved in 7%, and partial remission in 29% of the patients. In this group 6 patients (tumor stage: T3-4, N 2-3, M X-1) underwent a second-look operation after chemotherapy either to confirm the complete remission or the resect the remaining tumor mass. The mean follow-up time of these 6 patients is 22 (8-55) months; 4 are still in complete remission 8 to 55 months after the first operation. It is concluded that even in advanced stages of gastric carcinomas a more aggressive approach involving a combination of surgical and chemotherapeutic treatment improves the survival time of these patients.

摘要

42例晚期胃癌患者按照FAMTX方案接受化疗。7%的患者实现了肿瘤完全缓解,29%的患者实现了部分缓解。该组中有6例患者(肿瘤分期:T3 - 4,N 2 - 3,M X - 1)在化疗后接受了二次探查手术,目的是确认完全缓解或切除剩余肿瘤块。这6例患者的平均随访时间为22(8 - 55)个月;其中4例在首次手术后8至55个月仍处于完全缓解状态。结论是,即使在胃癌晚期,采用手术和化疗相结合的更积极治疗方法也能延长这些患者的生存时间。

相似文献

1
Advanced gastric cancer: a new combined surgical and oncological approach.进展期胃癌:一种新的外科与肿瘤学联合治疗方法。
Hepatogastroenterology. 1989 Feb;36(1):23-6.
2
[Initial results of combined surgical-medical therapy for metastatic cancer of the stomach].[胃癌转移性癌综合手术 - 药物治疗的初步结果]
Helv Chir Acta. 1990 Jun;57(1):73-6.
3
Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxorubicin, and cisplatinum. Closing results after 5 years of follow-up.依托泊苷、阿霉素和顺铂用于局部晚期胃癌患者的新辅助治疗。5年随访后的最终结果。
Cancer. 2001 Mar 1;91(5):918-27.
4
Neuroblastoma.神经母细胞瘤
Saudi Med J. 2001 Aug;22(8):674-80.
5
[The results of a modified FAMeth chemotherapy protocol in metastatic stomach carcinoma].
Dtsch Med Wochenschr. 1989 Sep 15;114(37):1391-6. doi: 10.1055/s-2008-1066771.
6
[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].[高风险和标准风险肝母细胞瘤的差异化治疗方案——德国肝脏肿瘤研究HB99的中期报告]
Klin Padiatr. 2003 May-Jun;215(3):159-65. doi: 10.1055/s-2003-39375.
7
The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.过去25年胃癌患者预后改善与手术及综合治疗方法变化之间的关系
Przegl Lek. 2000;57 Suppl 5:9-13.
8
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.接受保守多模式治疗的局部晚期膀胱癌患者的临床结局
Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088.
9
Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.新辅助化疗联合术中放疗(IORT)根治性切除术:改善胃腺癌治疗方法
Surgery. 2000 Oct;128(4):564-71. doi: 10.1067/msy.2000.108420.
10
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.根治性胃切除术后辅助化疗的晚期胃癌患者15年随访期间预后因素模式的变化:韩国一家机构的15年随访研究
Ann Surg Oncol. 2007 Oct;14(10):2730-7. doi: 10.1245/s10434-007-9479-4. Epub 2007 Jul 14.

引用本文的文献

1
Review of adjuvant chemotherapy for gastric cancer.胃癌辅助化疗综述
World J Surg. 1995 Jul-Aug;19(4):570-4. doi: 10.1007/BF00294725.